Tandem Diabetes Care (TNDM) Shares Outstanding (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Shares Outstanding data on file, last reported at $68.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 2.91% year-over-year to $68.5 million; the trailing twelve-month figure through Mar 2026 stood at $68.5 million (up 2.91% YoY), and the FY2024 full-year result was $66.3 million, up 1.09% from the prior year.
• Shares Outstanding for Q1 2026 stood at $68.5 million, up from $67.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $68.5 million in Q1 2026 and bottomed at $63.9 million in Q1 2022.
• The 5-year median for Shares Outstanding is $65.3 million (2023), against an average of $65.6 million.
• The widest annual swing landed in 2024, when Shares Outstanding retreated 0.07%; it then gained 3.24% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $64.5 million in 2022, then advanced by 1.61% to $65.6 million in 2023, then rose by 1.09% to $66.3 million in 2024, then rose by 2.28% to $67.8 million in 2025, then increased by 1.08% to $68.5 million in 2026.
• The last three Shares Outstanding figures came in at $68.5 million (Q1 2026), $67.8 million (Q3 2025), and $67.5 million (Q2 2025), per Business Quant data.

Peer Comparison